World Lifestyle Archives | Page 4 of 417 | Be Korea-savvy

Archive by category World Lifestyle

Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

– BPT958, a bifunctional PD-1 immunoconjugate with a masked IL-2 payload designed to be processed specifically in the tumor microenvironment - –In preclinical models, BPT958 induces potent antitumor activity with minimal systemic activation - BASEL, Switzerland and SAN DIEGO, Nov. 08, 2024 (Korea Bizwire) – Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering [...]

Smart City Expo closes a record-breaking edition focused on ethical urban development

Smart City Expo closes a record-breaking edition focused on ethical urban development

BARCELONA, Spain, Nov. 07, 2024 (Korea Bizwire) – Smart City Expo World Congress (SCEWC), the leading international summit on cities and smart urban solutions organized by Fira de Barcelona, closed its 2024 edition this afternoon after registering record-breaking figures and focusing on ethical urban development. SCEWC was held with Tomorrow.Mobility World Congress – organized with the [...]

Boris Herrmann aboard the Malizia-Seaexplorer under Monaco flag for the Vendée Globe, It’s the ultimate challenge

Boris Herrmann aboard the Malizia-Seaexplorer under Monaco flag for the Vendée Globe, It’s the ultimate challenge

TURIN, Italy, Nov. 07, 2024 (Korea Bizwire) – “Despite having done it before, this remains the ultimate challenge”. Boris Herrmann, German sailor and member of Yacht Club de Monaco, is ready to participate to the 10th edition of the Vendée Globe, the single-handed, non-stop, non-assisted round-the-world sailing race, taking place every 4 years since the 1989. [...]

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9

First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing Research Triangle Park, N.C., Nov. 07, 2024 (Korea Bizwire) – Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received [...]

MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters

MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters

MedSource Labs Unveils the most intensive remote training tools available to medical professionals, distributors and students. [Minneapolis, Minnesota, Chanhassen], Nov. 07, 2024 (Korea Bizwire) – MedSource Labs and its production partner, Ghost Medical, proudly announce the first training modules designed to improve patient care, comfort and clinician accuracy in peripheral IV Catheters. Through first-of-its-kind digital [...]

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass, Nov. 07, 2024 (Korea Bizwire) – Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, [...]

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis

ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis

UTRECHT, The Netherlands, Nov. 07, 2024 (Korea Bizwire) – Today, ATNi launches the 5th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 products, representing 23% global market share. One in five deaths globally is associated with a poor diet. One out [...]

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

For an accessible version of this Press Release, please visit www.tevapharm.com Q3 2024 revenues of $4.3 billion reflect an increase of 13% in U.S. dollars, or 15% in local currency terms, compared to Q3 2023. AUSTEDO® – shows continued growth, U.S. revenues of $435 million in Q3 2024, an increase of 28% compared to Q3 2023; reaffirming [...]

Malizia-Seaexplorer competing in Vendée Globe under Monaco flag

Malizia-Seaexplorer competing in Vendée Globe under Monaco flag

TURIN, Italy, Nov. 05, 2024 (Korea Bizwire) – Everything’s ready for the 10th edition of the Vendée Globe, the single-handed, non-stop, non-assisted round-the-world sailing race that takes place every four years since 1989. Forty sailors will set out on November 10th from Les Sables-d’Olonne, in France, and among them there will be Boris Herrmann, member [...]

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell lung cancers VANCOUVER, British Columbia, Nov. 05, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard [...]